What is Emmaus Life Sciences Inc?
, a commercial-stage biopharmaceutical company, discovers, develops, markets, and sells treatments and therapies primarily for rare and orphan diseases in the United States and internationally.
The story behind the price, the case for and against, and what could go wrong. Open a part to read it.
, a commercial-stage biopharmaceutical company, discovers, develops, markets, and sells treatments and therapies primarily for rare and orphan diseases in the United States and internationally. The company's lead candidate is Endari, an L-glutamine oral powder to reduce the acute complications of sickle cell disease (SCD) in adult and pediatric patients five years of age and older. The company is listed on the OTCQB in USA, operating in the Healthcare sector, with a market capitalisation of 982.77K.
A short list of Biotechnology names that are close enough in size to make side-by-side comparison useful.